Navidea Biopharmaceuticals   Report issue

Contributed to NME For profit Phase 3 Phase 4
Founded: Dublin OH United States (1983)
Status: Acquired by Devicor Medical Products (2011) → now Danaher (2005)

Organization Overview

First Clinical Trial
2008
NCT00671918
First Marketed Drug
2013
tc99m-tilmanocept (Lymphoseek)
First NDA Approval
2013
tc99m-tilmanocept (Lymphoseek)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Navdiea Biopharmaceuticals | Navidea | Navidea Biopharmaceuticals | Navidea Biopharmaceuticals Inc. | Navidea Biopharmaceuticals, Inc. | Neoprobe